MCID: CHL013
MIFTS: 37

Cholecystolithiasis

Categories: Gastrointestinal diseases

Aliases & Classifications for Cholecystolithiasis

MalaCards integrated aliases for Cholecystolithiasis:

Name: Cholecystolithiasis 12 43 15 17 71

Classifications:



External Ids:

Disease Ontology 12 DOID:11151
MeSH 43 D041761
NCIt 49 C34443
SNOMED-CT 67 235919008
UMLS 71 C0947622

Summaries for Cholecystolithiasis

MalaCards based summary : Cholecystolithiasis is related to ascending colon cancer and ileus. An important gene associated with Cholecystolithiasis is UVRAG (UV Radiation Resistance Associated), and among its related pathways/superpathways is Hippo signaling pathway. The drugs Esketamine and Ketamine have been mentioned in the context of this disorder. Affiliated tissues include pancreas, liver and skin.

Wikipedia : 74 A gallstone is a stone formed within the gallbladder out of bile components. The term cholelithiasis may... more...

Related Diseases for Cholecystolithiasis

Diseases related to Cholecystolithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 176)
# Related Disease Score Top Affiliating Genes
1 ascending colon cancer 30.5 UVRAG CEACAM5
2 ileus 30.3 SST CRP CCK
3 cholelithiasis 30.3 SST GPT CRP CCK
4 obstructive jaundice 30.1 TGFB1 GPT CRP
5 acute cholangitis 30.1 GPT CRP CEACAM5
6 active peptic ulcer disease 30.1 SST CRP
7 choledocholithiasis 30.0 STK10 GPT ERVMER34-1 CRP CEACAM5
8 duodenogastric reflux 30.0 SST CCK
9 liver cirrhosis 30.0 TGFB1 SST GPT CCN2
10 acalculous cholecystitis 30.0 GPT CRP CCK
11 pancreatitis 30.0 SST CRP CCK
12 cholangitis 29.7 SST GPT CRP CEACAM5
13 irritable bowel syndrome 29.7 SST CRP CCK
14 portal hypertension 29.6 TGFB1 SST GPT CCN2
15 acute pancreatitis 29.4 SST GPT CRP CCK
16 gallbladder disease 29.3 SST GPT CRP CEACAM5 CCK
17 gallbladder disease 1 11.7
18 cholecystitis 10.6
19 keloid disorder 10.4 TGFB1 BMP6
20 scleroderma, familial progressive 10.4 CCN2 BMP6
21 autoimmune hepatitis type 1 10.4 GPT BMP6
22 dupuytren contracture 10.4 TGFB1 BMP6
23 nephrogenic systemic fibrosis 10.4 TGFB1 CCN2
24 hypertrophic scars 10.4 TGFB1 BMP6
25 urethral stricture 10.4 TGFB1 CCN2
26 pulmonary arterial hypertension associated with congenital heart disease 10.4 CRP CCN2
27 diffuse scleroderma 10.4 TGFB1 CCN2
28 external ear carcinoma 10.3 CRP CEACAM5
29 sarcomatous intrahepatic cholangiocarcinoma 10.3 GPT CEACAM5
30 ocular cicatricial pemphigoid 10.3 TGFB1 CCN2
31 tuberculous peritonitis 10.3 CRP CEACAM5
32 pericardial tuberculosis 10.3 CRP CEACAM5
33 marantic endocarditis 10.3 CRP CEACAM5
34 eosinophilia-myalgia syndrome 10.3 TGFB1 BMP6
35 bile duct cysts 10.3 GPT CEACAM5
36 ascending cholangitis 10.3 GPT CRP
37 tuberculoid leprosy 10.3 TGFB1 BMP6
38 ankylosing spondylitis 1 10.3 GPT CRP
39 gastrointestinal tuberculosis 10.3 CRP CEACAM5
40 laryngitis 10.3 TGFB1 CRP
41 splenic abscess 10.3 GPT CRP
42 duodenal obstruction 10.3 CRP CEACAM5
43 critical illness polyneuropathy 10.3 GPT CRP
44 parenteral nutrition-associated cholestasis 10.3 GPT CCK
45 tinea unguium 10.3 GPT CRP
46 granulomatous hepatitis 10.3 GPT CRP
47 lymphangitis 10.3 CRP CEACAM5
48 viral laryngitis 10.3 GPT CRP
49 female urethral cancer 10.3 ERVMER34-1 CEACAM5
50 heart aneurysm 10.3 GPT CRP

Graphical network of the top 20 diseases related to Cholecystolithiasis:



Diseases related to Cholecystolithiasis

Symptoms & Phenotypes for Cholecystolithiasis

Drugs & Therapeutics for Cholecystolithiasis

Drugs for Cholecystolithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 128)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Esketamine Approved, Investigational Phase 4 33643-46-8
2
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
3
Droperidol Approved, Vet_approved Phase 4 548-73-2 3168
4
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
5
tannic acid Approved Phase 4 1401-55-4
6
Benzocaine Approved, Investigational Phase 4 94-09-7, 1994-09-7 2337
7
Flurbiprofen Approved, Investigational Phase 4 5104-49-4 3394
8
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
9
Levobupivacaine Approved, Investigational Phase 4 27262-47-1 92253
10
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
11
Ondansetron Approved Phase 4 99614-02-5 4595
12
chenodeoxycholic acid Approved Phase 4 474-25-9 10133
13
Remifentanil Approved Phase 4 132875-61-7 60815
14
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
15
Granisetron Approved, Investigational Phase 4 109889-09-0 3510
16
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
17
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
18
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
19
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
20
Esmolol Approved Phase 4 103598-03-4, 81147-92-4 59768
21
Morphine Approved, Investigational Phase 4 57-27-2 5288826
22
Ephedrine Approved Phase 4 299-42-3 9294
23
Pseudoephedrine Approved Phase 4 90-82-4 7028
24
Neostigmine Approved, Vet_approved Phase 4 59-99-4 4456
25
Atropine Approved, Vet_approved Phase 4 51-55-8, 5908-99-6 174174
26
Sulbactam Approved Phase 4 68373-14-8
27
Ampicillin Approved, Vet_approved Phase 4 69-53-4 6249
28
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
29
Sultamicillin Approved, Investigational Phase 4 76497-13-7
30
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
31
Aspartic acid Approved, Nutraceutical Phase 4 56-84-8 5960
32
Tauroursodeoxycholic acid Experimental, Investigational Phase 4 14605-22-2 12443252
33 Flurbiprofen axetil Investigational Phase 4 91503-79-6
34 Antiviral Agents Phase 4
35 Dopamine Agents Phase 4
36 Excitatory Amino Acid Antagonists Phase 4
37 Dopamine Antagonists Phase 4
38 Antidepressive Agents Phase 4
39 Anesthetics, Dissociative Phase 4
40 Anticonvulsants Phase 4
41 Anesthetics, Local Phase 4
42 Sodium Channel Blockers Phase 4
43 Neurotransmitter Agents Phase 4
44 Anti-Anxiety Agents Phase 4
45 Anti-Arrhythmia Agents Phase 4
46 Psychotropic Drugs Phase 4
47 Anesthetics, General Phase 4
48 Antiemetics Phase 4
49 Diuretics, Potassium Sparing Phase 4
50 Anesthetics, Intravenous Phase 4

Interventional clinical trials:

(show top 50) (show all 168)
# Name Status NCT ID Phase Drugs
1 The Discovery of the Double Sphincter in Gallbladder Unknown status NCT01998451 Phase 4 Tauroursodeoxycholic acid
2 Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy Unknown status NCT00209885 Phase 4 Gabapentin;S-ketamine;Lidocaine;Droperidol
3 Randomised Controlled Trail of Warmed Humidified Insufflation Versus Cold Non-Humidified Insufflation in Elective Laparoscopic Cholecystectomies: Does This Reduce Post-Operative Pain? Unknown status NCT00792389 Phase 4
4 Closed-Loop Target Controlled Infusion of Propofol and Remifentanil Guided by Narcotrend Index in Laparoscopic Cholecystectomy Unknown status NCT02114437 Phase 4
5 DOLCE Study: Day-care Versus Overnight-stay Laparoscopic Cholecystectomy Randomized, Controlled Trial Unknown status NCT01052727 Phase 4
6 Effects of Calot's Triangle Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy: a Prospective, Randomized, Double-blind, Controlled, Clinical Trial Unknown status NCT02300480 Phase 4
7 Laparo-endoscopic Single Site Cholecystectomy Versus Standard Laparoscopic Cholecystectomy Unknown status NCT01339325 Phase 4
8 Effects of Intraperitoneal Levobupivacaine on Pain After Laparoscopic Cholecystectomy: A Prospective, Randomized, Double-Blinded Study Completed NCT00836316 Phase 4 levobupivacaine
9 Combined Preincisional Infiltration and Intraperitoneal Instillation of Levobupivacaine for Postoperative Pain Reduction After Laparoscopic Cholecystectomy; A Double-blind Placebo-controlled Randomised Clinical Trial Completed NCT01199406 Phase 4 Levobupivacaine
10 Study of Oxidative Stress in Standard Laparoscopic vs Single Port Cholecystectomy for Uncomplicated Cholelithiasis (Lap vs SILS) Completed NCT01211743 Phase 4
11 Effect of Acupuncture on Postoperative Nausea and Vomiting Completed NCT00674713 Phase 4 Ondansetron;Physiological saline solution;Ondansetron;Physiological saline solution
12 Robotic Assisted Versus Laparoscopic Cholecystectomy - Completed NCT00562900 Phase 4
13 Laparoscopic Guided Regional Analgesia (LaGRA) Reduces Post Operative Pain After Laparoscopic Cholecystectomy - a Randomised, Controlled Trial. Completed NCT03394807 Phase 4 Levobupivacaine;Placebo
14 Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy Completed NCT03168555 Phase 4 chenodeoxycholic acid
15 Studie Naar De Effectiviteit Van Ursodeoxycholzuur Ter Preventie Van Galsteen-Gerelateerde Klachten Bij patiënten in Afwachting Van Een Cholecystectomie Completed NCT00161083 Phase 4 ursodeoxycholic acid
16 Dual-Loop Target Controlled Infusion of Propofol and Remifentanil Guided by Narcotrend Index in Laparoscopic Cholecystectomy Completed NCT02116985 Phase 4
17 Cholecystocholangiography Versus Cystic Duct Cholangiography During Laparoscopic Cholecystectomy: A Prospective Controlled Randomized Trial Completed NCT01103570 Phase 4
18 Granisetron Effect on Hemodynamic Changes and Intubation Condition During Anesthesia Induction in Laparoscopic Cholecystectomy Completed NCT03180229 Phase 4 Granisetron 1 Mg/mL Intravenous Solution
19 Effect of Endovenous Lidocaine on Analgesia and Serum Cytokines Concentration: Randomized and Double-blind Trial Completed NCT02363699 Phase 4 Lidocaine;Saline solution
20 Minilaparoscopic Versus Conventional Laparoscopic Cholecystectomy: A Randomized Trial Completed NCT01397565 Phase 4
21 Intraoperative Lidocaine Infusion vs. Esmolol Infusion for Postoperative Analgesia in Laparoscopic Cholecystectomy: a Randomized Clinical Trial Completed NCT02327923 Phase 4 Lidocaine;Esmolol;Paracetamol;Lidocaine;Propofol;Fentanyl;Vecuronium;Atropine;Ephedrine;Morphine;Ketorolac;Ondansetron;Bupivacaine;Tramadol;Neostigmine;Glycopyrrolate
22 Multi-Port vs. Single-port Cholecystectomy Completed NCT01104727 Phase 4
23 All the Phases Study Will be Operated by the Department of Hepatobiliary Surgery, The Affiliated Hospital of Guiyang Medical College Recruiting NCT01822262 Phase 4
24 Is an Antibiotic Prescription Required After Laparoscopic Cholecystectomy for Acute Calculous Cholecystitis? Not yet recruiting NCT04290104 Phase 4 1gr oral ampicillin/sulbactam group
25 Ciprofloxacin, Ampicillin-sulbactam and Placebo Prophylaxis in Laparoscopic Cholecystectomy. A Randomized Controlled Study Terminated NCT01888822 Phase 4 Ciprofloxacin;Ampicillin-sulbactam;Placebo
26 Biliary Lithotripsy in Combination With Actigall Versus Actigall Monotherapy for the Treatment of Symptomatic Cholesterol Gallstones Terminated NCT00042549 Phase 4 ursodiol
27 The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders Terminated NCT02472509 Phase 4 Ursodeoxycholic Acid
28 Use of IV Acetaminophen Intraoperatively in Obese Patients at Risk for Obstructive Sleep Apnea Undergoing Laparoscopic Cholecystectomy Withdrawn NCT02056678 Phase 4 acetaminophen, IV preparation
29 Single Port Access Cholecystectomy Versus Standard Laparoscopic Cholecystectomy - Randomized Study Unknown status NCT00904865 Phase 2, Phase 3
30 Effectiveness of Ursodeoxycholic Acid Use in the Prevention of Gallstone Formation After Sleeve Gastrectomy: A Prospective Randomized Multicenter Placebo-Controlled Trial Unknown status NCT02721862 Phase 3 Ursodeoxycholic Acid;Placebo
31 Efficacy and Safety of Renalof Administration in the Treatment of Elderly Patients With Gallstones Completed NCT01099319 Phase 3
32 Prospective Randomized Clinical Trial Comparing Laparoscopic Cholecystectomy and Hybrid Natural Orifice Translumenal Endoscopic Surgery (NOTES) Completed NCT00835250 Phase 3
33 Combined Sphincterotomy and Balloon Dilation (ESBD) Versus Standard Sphincterotomy (ES) in Removing Biliary Stones—a Randomized Controlled Trial Completed NCT00164853 Phase 3
34 An Expertise-based Randomized Controlled Trial Comparing Minilaparotomy Cholecystectomy and Laparoscopic Cholecystectomy Completed NCT00370344 Phase 2, Phase 3
35 Prospective Randomized Clinical Trial Comparing Single Incision Laparoscopic Surgery vs Flexible Single Incision Surgery on Cholecystectomy Completed NCT01558414 Phase 3
36 Treatment of Suspected Cholelithiasis With Nitroglycerin: a Randomized, Prospective Double-blind Trial Unknown status NCT01715220 Phase 2 sublingual nitroglycerine
37 Effects of Obeticholic Acid on Hepatic Fatty Acid/Triglyceride Metabolism and Hepatobiliary Detoxification/Elimination in Morbidly Obese and Gallstone Patients Completed NCT01625026 Phase 2 Obeticholic acid;Placebo
38 Transvaginal Natural Orifice Translumenal and Endoscopic Surgery (NOTES) Cholecystectomy vs. Laparoscopic Cholecystectomy: Phase I/II Clinical Trial Completed NCT00710502 Phase 1, Phase 2
39 Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy Terminated NCT00910325 Phase 1, Phase 2
40 Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study Terminated NCT02325492 Phase 2 Aramchol;Placebo
41 Single Incision Laparoscopic Cholecystectomy Completed NCT00678873 Phase 1
42 Laparoscopic Cholecystectomy Using Transvaginal Endoscopic Assistance Withdrawn NCT00815438 Phase 1
43 Comparison of Single Trocar Cholecystectomy to Standard Laparoscopic Cholecystectomy Unknown status NCT00732550
44 Clinical Application of Cholangiojejunostomy in the Surgical Treatment of Cholelithiasis With Moderate Dilatation of Common Bile Duct Unknown status NCT02915770
45 Randomised Non-inferiority Trial of Laparoscopic Cholecystectomy Performed With EndoCone Single Port Versus Conventional Multi-port Laparoscopic Approach Using Clinical, PROMS and Health Economic Endpoints Unknown status NCT01709877
46 Three-dimensional High-definition (3DHD) Laparoscopy Versus Two-dimensional High-definition (2DHD) Laparoscopy in Cholecystectomy: a Clinical Controlled Randomized Double Blinded Trial. Unknown status NCT02396927
47 Clinical Study of Abdominal Drainage in Laparoscopic Common Bile Duct Exploration With Primary Closure Unknown status NCT03120754
48 Effect of Vitamin C on Postoperative Pain After Laparoscopic Cholecystectomy; a A Prospective Randomized Controlled Trial Unknown status NCT02553551 Vitamin C;Placebo
49 Natural Orifice Translumenal Endoscopic Surgery (NOTES): Laparoscopic Assisted Transgastric Appendectomy and Cholecystectomy Unknown status NCT00531219
50 Cosmesis and Body Image After Single Port Laparoscopic or Conventional Laparoscopic Cholecystectomy: A Double Blinded Randomised Controlled Trial Unknown status NCT01278472

Search NIH Clinical Center for Cholecystolithiasis

Cochrane evidence based reviews: cholecystolithiasis

Genetic Tests for Cholecystolithiasis

Anatomical Context for Cholecystolithiasis

MalaCards organs/tissues related to Cholecystolithiasis:

40
Pancreas, Liver, Skin, Colon, Testes, Lymph Node, Heart

Publications for Cholecystolithiasis

Articles related to Cholecystolithiasis:

(show top 50) (show all 910)
# Title Authors PMID Year
1
Laparoscopic transcystic common bile duct exploration (LTCBDE): a safer method to treat common bile duct stones than laparoscopic choledochotomy. 61
32496116 2020
2
True single-port cholecystectomy with ICG cholangiography through a single 15-mm trocar using the new surgical platform "symphonX": first human case study with a commercially available device. 61
31659506 2020
3
The Clinical Application of a Self-developed Gasless Laparoendoscopic Operation Field Formation Device on Patients Undergoing Cholecystectomy. 61
32555068 2020
4
Gallbladder wall perforation secondary to empyema in Mirizzi's syndrome: An unseen complication. A case report. 61
32563837 2020
5
Secondary oxalosis induced by xylitol concurrent with lithium-induced nephrogenic diabetes insipidus: a case report. 61
32357847 2020
6
Rare recurrent gallstone ileus: A case report. 61
32518796 2020
7
Laparoscopy Versus Open Reoperation for Incidental Gallbladder Carcinoma After Laparoscopic Cholecystectomy. 61
32429744 2020
8
Axillary metastases after port site recurrences of gallbladder carcinoma: a case report. 61
32264915 2020
9
Application of Transparent Cap-assisted Choledochoscopy in Endoscopic Gallbladder-preserving Surgery. 61
32287110 2020
10
Bile Duct Stones Predict a Requirement for Cholecystectomy in Older Patients. 61
31654201 2020
11
Reconsideration of indications for choledochoscopic gallbladder-preserving surgery and preventive measures for postoperative recurrence of gallstones. 61
32117490 2020
12
Role of gallbladder-preserving surgery in the treatment of gallstone diseases in young and middle-aged patients in China: results of a 10-year prospective study. 61
31606197 2020
13
[Gallbladder Cancer with Multiple Liver Metastases Completely Responding to Gemcitabile plus Cisplatin Chemotherapy-A Case Report]. 61
32381990 2020
14
TJP2 hepatobiliary disorders: Novel variants and clinical diversity. 61
31696999 2020
15
Cholecystohepatic duct detected during laparoscopic cholecystectomy: a case report. 61
31932993 2020
16
A rare complication of gallstones ended with spontaneous cholecystocutaneus fistula in an old man: A case report. 61
32004903 2020
17
Transgastric endoscopic gallbladder polypectomy and cholecystolithiasis: A case report. 61
31853277 2020
18
Mirizzi Syndrome with Cholecystobiliary Fistula: Observation of Development from Asymptomatic Cholecystolithiasis to Surgery. 61
32047697 2020
19
Clinical Efficacy Analysis of the Combination of the Laparoscope and Preoperative or Intraoperative Duodenoscope in the Treatment of Cholecystolithiasis with Choledocholithiasis: A Retrospective Study. 61
31647359 2019
20
Characteristics of amino acid profiles and incretin hormones in patients with gallstone disease: a pilot study. 61
31553330 2019
21
Laparoscopic cholecystectomy for cholecystolithiasis with Dubin-Johnson syndrome. 61
31832555 2019
22
Gallstone formation due to rapid weight loss through hyperthyroidism. 61
31730531 2019
23
Early-stage T1b adenocarcinoma arising in the remnant cystic duct after laparoscopic cholecystectomy: a case report and literature review. 61
31783817 2019
24
Non-obstetric surgery during pregnancy - an eleven-year retrospective analysis. 61
31653246 2019
25
Inferior pancreaticoduodenal artery pseudoaneurysm in a patient with calculous cholecystitis: A case report. 61
31616702 2019
26
Endoscopic mucosal resection of a bile duct polyp: A case report. 61
31616704 2019
27
Prevalence of dyspepsia in patients with cholecystolithiasis: a systematic review and meta-analysis. 61
31206407 2019
28
Laparoscopic transcystic common bile duct exploration and laparoscopic transductal common bile duct exploration in elderly patients with cholecystolithiasis combined with choledocholithiasis. 61
31261208 2019
29
Needleless Transcutaneous Neuromodulation Accelerates Postoperative Recovery Mediated via Autonomic and Immuno-Cytokine Mechanisms in Patients With Cholecystolithiasis. 61
30277014 2019
30
Comorbidities Associated with Large Abdominal Aortic Aneurysms. 61
31805597 2019
31
PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway. 61
31182136 2019
32
Clinical analysis of prophylactic cholecystectomy during gastrectomy for gastric cancer patients: a retrospective study of 1753 patients. 61
31088424 2019
33
[Diagnosis and treatment for unexpected gallbladder carcinoma(a retrospective study of 45 cases)]. 61
30929371 2019
34
[Differential diagnosis of gallbladder abnormalities : Ultrasound, computed tomography, and magnetic resonance imaging]. 61
30789997 2019
35
Hem-o-lok clip found in the common bile duct 3 years after laparoscopic cholecystectomy and surgical exploration. 61
30616484 2019
36
Single-Stage Endoscopic Stone Extraction and Cholecystectomy during the Same Hospitalization. 61
30300983 2019
37
Gallstone ileus: a review. 61
31875141 2019
38
Combination of serum gamma-glutamyltransferase and alkaline phosphatase in predicting the diagnosis of asymptomatic choledocholithiasis secondary to cholecystolithiasis. 61
30705891 2019
39
Clonorchiasis sinensis detected by laparoscopic exploration of biliary tracts in two patients with obstructive jaundice. 61
30621611 2019
40
Myotonic Dystrophy-2: Unusual Phenotype Due to a Small CCTG-expansion. 61
30984523 2018
41
Hemolytic jaundice induced by pharmacological dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency: A case report. 61
30572463 2018
42
A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report. 61
30383632 2018
43
Statistical analysis plan of a randomized controlled trial to compare a restrictive strategy to usual care for the effectiveness of cholecystectomy (SECURE trial). 61
30390706 2018
44
[Minimally invasive robot-assisted gastric bypass after open Mason reduction gastroplasty]. 61
30135966 2018
45
Axillo-Axillary Artery Bypass With Coil Embolization of the Innominate Artery for a Traumatic Innominate Artery Aneurysm: A Case Report. 61
29807496 2018
46
Learning curve for performing choledochotomy bile duct exploration with primary closure after laparoscopic cholecystectomy. 61
29602995 2018
47
Distribution of the ATP-binding cassette transporter ABCG8 IVS1-2A>G genotype and clinical characteristics of gallbladder patients in Northeastern Mexico: A pilot study. 61
30271604 2018
48
Sarcomatous intrahepatic cholangiocarcinoma: Case report and literature review. 61
30278551 2018
49
Pseudo-Wellens' syndrome and intermittent left bundle branch block in acute cholecystitis. 61
29661666 2018
50
A 0.8-cm clear cell neuroendocrine tumor G1 of the gallbladder with lymph node metastasis: a case report. 61
30037336 2018

Variations for Cholecystolithiasis

Expression for Cholecystolithiasis

Search GEO for disease gene expression data for Cholecystolithiasis.

Pathways for Cholecystolithiasis

Pathways related to Cholecystolithiasis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11 TGFB1 CCN2 BMP6

GO Terms for Cholecystolithiasis

Cellular components related to Cholecystolithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.5 TGFB1 SST GPT CRP CCN2 CCK
2 extracellular region GO:0005576 9.23 TGFB1 SST ERVMER34-1 CRP CEACAM5 CCN2

Biological processes related to Cholecystolithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.73 TGFB1 CRP CCN2 BMP6
2 positive regulation of collagen biosynthetic process GO:0032967 9.4 TGFB1 CCN2
3 positive regulation of superoxide anion generation GO:0032930 9.37 TGFB1 CRP
4 positive regulation of SMAD protein signal transduction GO:0060391 9.32 TGFB1 BMP6
5 receptor catabolic process GO:0032801 9.26 UVRAG TGFB1
6 positive regulation of vascular permeability GO:0043117 9.16 TGFB1 BMP6
7 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.13 TGFB1 CCK BMP6
8 connective tissue development GO:0061448 8.62 TGFB1 CCN2

Molecular functions related to Cholecystolithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 growth factor activity GO:0008083 8.8 TGFB1 CCN2 BMP6

Sources for Cholecystolithiasis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....